TickerFacts.

Polomar Health Services, Inc. (PMHS): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$9.77M
Year ended 2025-12-31
$9.27M
Trailing 12 months to 2026-06-30
2023-12-31: $5.8K2024-12-31: $263.3K2025-12-31: $9.77M$9.77M
2023-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$9.77Mn/m2026-05-06, From 2025-01-01
2024-12-31$263.3Kn/m2026-05-06, From 2024-01-01
2023-12-31$5.8Kn/a2025-05-22, From 2023-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Polomar Health Services, Inc. (PMHS)2025-12-31$9.77Mn/m
Lexaria Bioscience Corp. (LEXX)2025-08-31$87.8K+15.3%
PMGC Holdings Inc. (ELAB)2025-12-31$96.1Kn/m
Yarrow Bioscience, Inc. (YARW)2025-12-31$23.0K+475.0%
Quantum Cyber N.V. (QUCY)2025-12-31$615.7K-11.6%
Lipella Pharmaceuticals Inc. (LIPO)2024-12-31$2.9K+71.3%
Hyperion Defi, Inc. (HYPD)2024-12-31$1.13M+44.1%
Onconetix, Inc. (ONCO)2025-12-31$15.2K-97.9%
Rallybio Corp (RLYB)2025-12-31$92.0K-29.8%

Compare PMHS, LEXX, ELAB, YARW side by side · Screen every company in Pharmaceutical Preparations ↗